![Sean Cassidy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
En la actualidad, Sean A. Cassidy es director financiero de Arvinas, Inc. y director financiero de Arvinas Operations, Inc. (una filial de Arvinas, Inc.) y tesorero de The Friends of Yale New Haven Children's Hospital. En el pasado, el Sr. Cassidy ocupó el cargo de Director Financiero y Vicepresidente de Administración en Renetx Bio, Inc., Director Financiero y Vicepresidente de CuraGen Corp., Director y Contralor en Deloitte & Touche LLP y Director y Contralor en 454 Life Sciences Corp. Obtuvo un MBA y una licenciatura en la Universidad de Connecticut.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HOOKIPA PHARMA INC. -.--% | 04/06/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HOOA PHARPAR | Director/Miembro de la Junta | 22/07/2024 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Director Financiero/CFO | - |
The Friends of Yale New Haven Children's Hospital | Treasurer | - |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Director/Miembro de la Junta | - |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ARVINAS, INC. | Director Financiero/CFO | 29/02/2024 |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Director Financiero/CFO | 01/06/2013 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Director Financiero/CFO | 01/10/2009 |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Director/Miembro de la Junta | 01/12/2008 |
| ░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
The Friends of Yale New Haven Children's Hospital | |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
